A 40-year Follow-up of Patients with Obsessive-compulsive Disorder [see Commetns]
Overview
Affiliations
Background: The long-term course of obsessive-compulsive disorder is insufficiently known. We studied the course of this disorder in patients who were followed up for 40 years.
Methods: Patients admitted with a diagnosis of obsessive-compulsive disorder to the Department of Psychiatry, Sahlgrenska University Hospital, Göteborg, Sweden, between 1947 and 1953 were examined by an experienced psychiatrist using a semistructured interview between 1954 and 1956 (n=251). The diagnosis was made according to the criteria of Schneider. A reexamination was performed by the same psychiatrist between 1989 and 1993 (n=122). In another 22 patients, the necessary information was obtained from close informants and medical records. The response rate in surviving patients was 82%. The mean length of follow-up from onset was 47 years.
Results: Improvement was observed in 83%, including recovery in 48% (complete recovery, 20%; recovery with subclinical symptoms, 28%). Among those who recovered, 38% had done so already in the 1950s. Forty-eight percent had obsessive-compulsive disorder for more than 30 years. Early age of onset, having both obsessive and compulsive symptoms, low social functioning at baseline, and a chronic course at the examination between 1954 and 1956 were correlated with a worse outcome. Magical obsessions and compulsive rituals were correlated with a worse course. Qualitative symptom changes within the obsessive-compulsive disorder occurred in 58% of the patients.
Conclusion: After several decades, most individuals with obsessive-compulsive disorder improve, although most patients continue to have clinical or subclinical symptoms.
Kohls E, Baldofski S, Scholl J, Flygare O, Lundstrom L, Beyrich-Kolbus U BMC Psychiatry. 2025; 25(1):85.
PMID: 39885463 PMC: 11783832. DOI: 10.1186/s12888-025-06519-7.
Tjelle K, Opstad H, Solem S, Kvale G, Wheaton M, Bjorgvinsson T BMC Psychiatry. 2024; 24(1):327.
PMID: 38689256 PMC: 11059693. DOI: 10.1186/s12888-024-05780-6.
Chen L, Naesstrom M, Halvorsen M, Fytagoridis A, Crowley S, Mataix-Cols D Am J Med Genet B Neuropsychiatr Genet. 2024; 195(8):e32983.
PMID: 38650085 PMC: 11493841. DOI: 10.1002/ajmg.b.32983.
Voderholzer U, Meule A, Koch S, Pfeuffer S, Netter A, Lehr D JMIR Ment Health. 2024; 11:e52790.
PMID: 38477970 PMC: 10973968. DOI: 10.2196/52790.
Matsumoto K, Hamatani S, Shimizu E Internet Interv. 2024; 35:100725.
PMID: 38362159 PMC: 10867335. DOI: 10.1016/j.invent.2024.100725.